United States / New York / Services / Beauty
 
Post# A1229543

Laurus Labs shares drop on weak quarter (New York City)

Posted on: Tuesday, 29 April, 2025  06:25
Updated On: Tuesday, 29 April, 2025  06:32
Expires On: Monday, 24 January, 2028  13:25
Reply to: (Use contact form below)
Laurus Labs Ltd faced a significant drop in its stock price, hitting a lower circuit during Thursday’s trading session. The pharmaceutical company reported a challenging performance in the December 2023 quarter, leading to mixed reviews by brokerage firms. The net profit for the quarter was 23.84 crore, marking an 88.5% YoY decline, primarily driven by a 67% YoY fall in the CDMO-synthesis business. In the same period the previous year, the company had reported a bottom line of 203.06 crore.

For more details please visit our website : https://www.medhealthinsight.com/new-soundboard-review-pricing-is-not-always-the-only-criteria-2-11-2-33/


It is NOT ok to contact this poster with commercial interests.

8 hits

Contact this User: 
 
Your email: *
Message: *
Attachment:
The following file types are not allowed: exe, com, bat, vbs, js, jar, scr, pif
Maximum file size: 200KB
Security Code: *
Enter the code shown above into this textbox